Please use this identifier to cite or link to this item:
|Title:||Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007-2013)||Authors:||Pedrazzoni, Mario
|Keywords:||Atypical femoral fractures;Bisphosphonates;Epidemiology;Osteoporosis||Keywords Plus:||DIAPHYSEAL FRACTURES;RISK-FACTORS;BISPHOSPHONATES||Issue Date:||Sep-2017||Publisher:||SPRINGER JAPAN KK||Journal:||Journal of bone and mineral metabolism||Abstract:||
The aim of this study was to determine the incidence of atypical femoral fractures (AFFs) seen in a large emergency department in Italy. It was a retrospective study of all men and women aged 40 years or older admitted to the Emergency Department of Parma University Hospital for a femoral fracture. Cases were identified in the hospital database with use of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 820 or 821 or text strings. All the radiographic images of fractures not clearly identified as proximal or condylar were retrieved and evaluated by three independent reviewers. Fractures were considered as atypical if all three reviewers agreed on at least four of five major features defined by the 2013 American Society for Bone and Mineral Research criteria. In the 7-year period (2007-2013), with a total follow-up of 1,383,154 patient-years, we found 22 AFFs in 21 patients, accounting for 7.1% of low-trauma subtrochanteric/femoral shaft fractures and 0.6% of all femoral fractures. The incidence was very low (1.6 in 100,000 patient-years in both sexes combined). In contrast, the incidence of classic fractures of the proximal end of the femur was at least two orders of magnitude higher (typical/atypical rate ratio 152). Bisphosphonate use was reported in 13 patients (62%; mean treatment duration 9 years; range 5-14 years). Among 286 patients with typical subtrochanteric/femoral shaft fractures, 20 were being treated with bisphosphonate (7%; odds ratio 22; 95% confidence interval 8-58; p < 0.001). This study confirms the very low incidence of AFFs in the largest Italian cohort of patients to date. Even though the risk is higher in patients treated with bisphosphonates, AFFs are very rare, and typical femoral fractures are at least 100-fold more frequent.
|Appears in Collections:||Articles|
Show full item record
checked on May 2, 2021
checked on Sep 1, 2020
WEB OF SCIENCETM
checked on Nov 26, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.